Figs Inc vs Rocket Lab USA Inc — how do they compare? Figs Inc trades at $15.78 (market cap $2.49B), while Rocket Lab USA Inc trades at $68.21 (market cap $43.74B). The key difference: Rocket Lab USA Inc is far larger — about 17.6× Figs Inc's market cap, and Figs Inc is trading nearer its 52-week high, Rocket Lab USA Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Figs Inc for 33 Days and Rocket Lab USA Inc for 29 Days on average.
| FIGS | RKLB | |
|---|---|---|
Market Cap | $2.49B | $43.74B |
Volume | 5,964,311 | 22,892,581 |
Sector | Consumer Cyclical | Industrials |
52-Week High | $17.12 | $150.23 |
52-Week Low | $6.90 | $39.48 |
Typical Hold Time | 33 Days | 29 Days |
Enterprise Value | $2.25B | $41.57B |
Signals from Pluang's Aura AI — not financial advice
FIGS stock trades at $14.98, up 6.54% today, with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with 2025 revenue of $631.10M and net income of $34.25M, showing significant improvement from 2024. Recent earnings beats and raised 2026 guidance indicate accelerating growth, while international sales surged 67% in Q2 2026.
The outlook remains positive with analyst consensus targeting $18.00 (20% upside), though the stock's premium valuation (P/E 45.39) presents risk. Key catalysts include continued international expansion and margin improvement, while execution risks and rich valuation multiples require monitoring for sustained momentum.
Rocket Lab (RKLB) trades at $68.40, down 4.89% today, amid bearish technical signals despite positive business developments. The company recently secured its largest-ever commercial Electron launch contract with Synspective for 20 missions, expanding its backlog to over 100 launches. Fundamentally, RKLB shows strong revenue growth with $602 million in 2025 and projected $769 million in 2026, though it remains unprofitable with negative margins. Analyst sentiment remains overwhelmingly bullish with 16 buy ratings and a $107 consensus price target, representing significant upside potential from current levels.
Rocket Lab presents a high-risk, high-reward opportunity with substantial growth potential in the expanding space economy offset by persistent losses and competitive threats from SpaceX. The company's expanding launch backlog and Neutron rocket development provide long-term catalysts, but investors must weigh the premium valuation against ongoing cash burn and execution risks in a capital-intensive industry.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →